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CHAPTER 1 
INTRODUCTION 
 A quiet epidemic, the Human Papilloma Virus (HPV) is a sexually transmitted disease 
(STD), which is the leading cause of genital warts and cervical cancer in women (Markowitz, 
2001). According to American Teacher (2007), a debate exists among parents regarding use of 
the cervical cancer vaccine named Gardasil, which is being manufactured by Merck & Co. The 
U.S. Food and Drug Administration approved this vaccine on June 8, 2006. The HPV vaccine 
intended to be administered to young girls and women ages nine through twenty six. The 
purpose of the vaccine is to help minimize the risk of cervical cancer. 
Vaccine Concerns 
According to NCSL (2011), CDC reports that approximately 20 million people in the 
United States are infected with HPV. There is no treatment for HPV as there are 30 strains of 
HPV that can affect at least half of sexually active people and there are no symptoms of which 
can disappear on their own (NCSL, 2011). Merck’s Gardisil is a vaccine that can target four 
strands of HPV that are linked to cervical cancer and genital wart cases (NCSL, 2011). A 
societal concern is that the vaccine may encourage young girls to become sexually active 
(Caputo, 2007). “It seems unlikely that a vaccine that prevents a small number of sexually 
transmitted infections which have no symptoms will cause girls to be promiscuous or have 
unsafe sex, as some have suggested” (NNII, 2007 p.3). One parent, Brenda Jannsen, expressed 
her disagreement to the vaccine as she has taught her children against pre-marital sex and she 
believes that if the vaccines are required by the government that will give teenagers the idea 
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that pre-marital sex is ok (Caputo, 2007). Another concern of the use of the vaccine is the 
acceptance factor as those who approve of the vaccine may disagree with mandating it for 
student immunization. The reason is because there are concerns about the drug costs, safety 
and parental rights (NCSL, 2011). 
It is not known if the vaccine has adverse side effects resulting from long- term effects. 
“Since our experience with this new vaccine is limited and not all women are exposed to high 
risk HPVs, some girls could experience rare vaccine adverse events not yet identified without 
a corresponding benefit”(NNII, 2007 p.3). The duration of the vaccine is unclear. Current 
studies indicate that the vaccine is effective for at least five years and there is research still 
being done to determine how long the protection will last (CDC, 2006). 
Operational Definitions 
 Gardasil is one of the first vaccines developed for HPV and was licensed by the FDA 
in June 2006. Gardisil protects against HPV types 6, 11, 16, and 18 (CDC, 2006). The vaccine 
has been recommended to be administered to girls between the ages of 11-12 or as early as the 
age of 9. It is recommended that the vaccine is administered prior to the onset of sexual activity 
(CDC, 2006). According to NNII (2007), it is also recommended that the vaccine be 
administered to females who may be sexually active, but have not yet been exposed to HPV. 
Gardisil has been tested on over 11,000 females (9-26 years of age) throughout various 
countries to include the United States (CDC, 2006). The clinical trials have proven to be 100% 
effective in preventing these specific strains of HPV (Kaiser, 2007). Despite the proven clinical 
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trials, there is a constant debate as to whether the vaccine should be a required vaccine for 
school aged girls.  
The adverse side effects of the vaccine are a major concern for many parents. “The 
most common side effects with Gardasil are: pain swelling, itching, bruising and redness at the 
injection site; headache; fever; nausea; dizziness; vomiting, and fainting” (Merck & Co., 2012 
p.1). Long term side effects are unknown due to the originality of the vaccine. According to 
CDC (2006), in June 2006, the ACIP voted to recommend the first vaccine developed to 
prevent cervical cancer and other diseases in females caused by certain types of genital HPV. 
Gardisil protects against four types of HPV of which 70% causes cervical cancer and 90% 
causes genital warts. The vaccine has been recommended for girls and women ages nine to 
twenty six only. The HPV vaccine is administered through a series of three shots over a 6-
month period. (CDC, 2006). Females should be given the vaccine before they are sexually 
active. The vaccine is most effective in girls/women who have not yet acquired any of the four 
HPV types covered by the vaccine. However, females who are sexually active may also benefit 
from the vaccine. Very few young women are infected with all four types of these HPV types. 
Thus, they would still get protection from those types they have not acquired (CDC, 2006).  
Legal Limitations 
Gardasil has been suggested as a mandatory vaccine to administer to girls before 
entering high school. According to Lancet (2006 p.1), “The Michigan Senate passed a bill on 
September 21, 2006, ruling that all girls entering sixth grade of school should be immunized.” 
Despite Michigan’s acceptance of this bill, it wasn’t received the same in other states, 
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therefore, the bill was not enacted in each state. For instance, in 2007, Texas Governor Rick 
Perry supported the bill, but it was rejected by legislation (Dart, 2011). Due to concerns about 
Gardisil, the federal panel opposed mandating it as a condition of school enrollment (Dart, 
2011). According to Dart (2011), Texas lawmakers approved a bill which prohibits officials 
from requiring administration of the vaccine for four years. According to NCLS (2011), since 
2006, in at least 41 states plus Washington, D.C., legislation has introduced the bill to require 
the vaccine, fund, or educate the public about the HPV Vaccine, and at least 20 states have 
enacted legislation. One of the debates for the use of the HPV vaccine is that the quadrivalent 
HPV vaccine will not eliminate the need for cervical cancer (Markowitz, 2007). Reason being, 
not all HPV types that cause cervical cancer are included in the contents of the vaccine 
(Markowitz, 2007). 
What is HPV? 
A major component of contracting HPV is the risk of having genital warts or cervical 
cancer. HPV is a disease that can be contracted by oral, vaginal penetration, and rubbing of the 
genitals. The use of condoms may not prevent the contraction of HPV, but it can certainly 
decrease the chances of contraction. According to NNII (2007), does state that the consistent 
use of condoms can be related to whether HPV will progress to cervical cancer. If a woman 
has a sexually transmitted disease and it is not treated or it is a reoccurring disease it can aid to 
the progression of having cervical cancer. 
 A person can contract the disease and be unaware because the symptoms may be 
dormant and in a non-detective state. HPV can lead to cervical cancer which is why the 
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discussion of vaccine use is debated whether it is necessary to require for administration 
starting with school age children and teenagers to help prevent the transmission of HPV once 
a person becomes sexually active. Another question is if the vaccine is effective for women 
who are already sexually active. HPV can be detected through pap smears. Irregular results 
from a pap smear would lead to a repeat checkup in six months. Males may never know that 
they have contracted it because genital warts may not develop and they have a low risk of 
developing anal or penile cancer, therefore, the signs of transmission is not easily detected. 
Many are misdiagnosed when genital warts appear because they are diagnosed with having 
herpes. According to Markowitz (2007 p.2), “Genital HPV is the most common sexually 
transmitted infection in the United States; an estimated 6.2 million persons are newly infected 
every year.” Unfortunately, HPV has not received the same national attention as other STDs 
despite the high number of cases. According to Markowitz (2007), it was reported in 2007 that 
an estimated 11, 100 cases were diagnosed and approximately 3,700 will die from cervical 
cancer.  
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CHAPTER 2 
LITERATURE REVIEW 
According to Mayeux (2005), the way to help people accept the vaccine is provide 
education and awareness of HPV and the vaccine. Persistent genital HPV infection can cause 
cervical cancer in women to include other types of anogenital cancers and genital warts in both 
men and women (Markowitz, 2007). It is important to understand that there are high and low 
risks of HPV. Low risk types can cause benign cervical cell changes and genital warts. High-
risk types act as carcinogens in the development of cervical and other anogenital cancer 
(Markowitz, 2007). “The FDA acknowledges that sexual activity with multiple partners is an 
essential part of the lifecycle of this virus” (Harrub, 2006 p.1-2). Continued education of the 
risk of cycling sexual activity is a must to help people understand that HIV/AIDS and other 
STD’s are not the only concerns of changing sexual partners.  Once people learn that HPV is 
not like other STD’s as it is a gateway that leads to cancerous diseases that can be challenging 
to cure.  
Many parents are concerned that the HPV school vaccination is only for girls. A school 
vaccination should not be required for one gender. The vaccine was approved for boys and 
young men in 2009 that protects against genital warts and is not recommended for pregnant 
women. Markowitz’s (2007) review of the vaccine states that, despite the low rates of genital 
warts, anal and penile cancers, men may still benefit from the vaccine as well. However, there 
has not been enough research to show the effectiveness in either of these categories. Data in 
2007, stated that the HPV vaccine is not licensed to administer to males due to lack of data 
provided for the efficacy in males for any age category (OHSU, 2007). The more information 
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acquired about HPV, the better. Abstaining from sexual activity is the surest way to prevent 
genital HPV infection. Otherwise, a monogamous relationship with an uninfected partner is a 
secondary strategy to help prevent future genital HPV infections.  
The idea of making the HPV vaccine mandatory in schools has been debated by 
legislation. There are no federal laws that require girls or adolescent females to get vaccinated 
for cervical cancer or genital warts. The other issue or concerns regarding the HPV vaccine 
are: parental concerns, decrease of cervical cancer screening, and questions regarding 
effectiveness of vaccine. A parental concern is whether administering the vaccine to girls will 
encourage sexual activity and lead to adverse effects. The second concern is whether 
immunized women will stop seeking cervical cancer screenings. Finally, another concern is if 
the vaccine will actually reduce transmission. (NNII, 2007)   
The CDC requires vaccinations to protect children from various types of disease. As 
for the HPV vaccination, the CDC has made universal recommendation for school age girls to 
receive the vaccination. The universal recommendation is to help remove a stigma associated 
with the HPV vaccine and make the vaccine eligible for funding (NNII, 2007). Most states 
permit religious and /or philosophical exemptions, in addition to exemption for medical 
contraindications. The discussion of the HPV vaccine is so that it can be added to the list of 
vaccines that is currently required for children to attend school. There have to be a lot of 
questions answered before all United States legislations will be onboard with this vaccine 
requirement.  
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Due to Merck being the only company currently producing the vaccine, they have a 
huge financial incentive to persuade states to mandate Gardasil. However, the controversy of 
the vaccine has caused Merck to lobbying its push to have state lawmakers require the vaccine 
for preteens (American Teacher, 2007). After word was out on the fact that Texas Gov. Rick 
Perry gained financial contributions from Merck to mandate the vaccine, the state House 
rescinded the order (American Teacher, 2007). According to American Teacher (2007), the 
push for mandate is the cause for the controversy stir rather than the vaccine itself. “The Texas 
Medical Association advises: Mandating a vaccine for a disease not spread by casual and/or 
occupational contact, only available to one gender represents considerable departure from past 
practice” (American Teacher, 2007, p.4). Many parents are confused on whether to have their 
daughter vaccinated or not due to their son is not required to receive the same vaccination. “On 
the other hand, Jo-Ann Lynch, a member of the Albuquerque, N.M. Teachers Federation, is a 
cervical cancer survivor who believes mandating the vaccine for school use is good” 
(American Teacher, 2007, p.4). In New Mexico, lawmakers are considering legislation that 
would require sixth grade girls be vaccinated for the HPV disease. According to American 
Teacher (2007), parents are hesitant to discuss cervical cancer with a twelve year old. Another 
concern of the vaccine mandate is that it will be considered a license for sexual activity among 
young adults (American Teacher, 2007). Vaccine or not parents need to talk to their children 
about diseases spread through sexual intercourse. 
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CHAPTER 3 
METHODOLOGY 
Research design 
The knowledge of the drug Gardasil for cervical cancer, and HPV based on data 
collected through surveys administered will be reviewed. A survey was administered to 
collect data for further discussion of this topic. The demographics of the surveyors will also 
be explored to determine if it’s a significant factor of the survey results. Homogeneous 
selection of participants were used to conduct the experiment due to the fact that the 
independent variables are women or gender specific. This procedure will be used to control 
the gender of the experiment. Women were randomly assigned individuals to take the survey. 
The participants were women who are also mothers located either in the inner-city or rural 
area. It was important to attain information from mothers on their knowledge of HPV, the 
HPV vaccine, whether they would want the HPV immunization be a requirement or optional 
and how they will most likely seek information on HPV and the HPV vaccine.  
Research Hypothesis  
The hypothesis of the study is that the results will prove that lack of knowledge of 
HPV and the HPV vaccine can contribute to the decision of a mother allowing her school age 
child to be administered the vaccine whether by school mandate or voluntarily.  
Research Protocol 
Assistance was requested from an educator colleague to administer the survey 
(Appendix B) to the sample of women in the state of Michigan in the rural area and the 
primary surveyor administered the survey to women in the inner-city. A letter was distributed 
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to each participant providing information on the purpose of the survey and request for 
completion (Appendix A) prior to completing the survey.  
Sample 
The survey was administered to forty-three women from Michigan who identified 
themselves as mothers. The sample included 20 white females and 23 black females who 
completed the survey. Thirty-nine of the participants had children between the ages of nine to 
nineteen and four had children either below the age of nine or older than nineteen. The data 
was computed through a one-way sample (Table 3) and ANOVA (Table 4) to analyze the 
participant responses to the questions regarding the knowledge of HPV, the HPV vaccine and 
whether that affects the participant’s decision to allow their daughter to receive the vaccine 
and their opinion as to whether they believe the vaccine should be school mandated.  
Instrument  
 Participants completed the Survey on Parental Choice for HPV for Daughters 
(Appendix B). The survey was designed to be anonymous, therefore, participants would not 
have to be concerned with the identity of their answers being disclosed in reporting. The 
questionnaire consisted of three subscales and sixteen questions. These subscales measured the 
age of daughter to correlate the age groups to the question on the mother’s willingness to have 
their daughter vaccinated, the mother’s willingness to have daughter vaccinated as school 
mandate, the mother’s knowledge of HPV and HPV vaccine, and the demographics of the 
mothers to include race, and marital status. 
Data Analysis  
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The data analysis techniques that will be used include review of survey data through 
SPSS output of results.  Each survey will be reviewed and the data from each survey will be 
tallied according to each question. As the numbers of answers are grouped, the results will be 
input into SPSS for further analysis. Descriptive statistics of the mean averages of participants 
who have daughters, the participant knowledge of HPV, and their knowledge of the HPV 
vaccine will be reflected in the table data.  Cronbach’s Alpha is .883 for questions 6, 7 and 14. 
Tables 6, 7 and 8 will reflect the data analysis of the reliability for those three survey questions. 
The bar figures reflect the data of the survey results according to the race demographic.  It 
became evident in reviewing the survey results that the race demographic was most significant 
on the impact of the participant responses.   
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CHAPTER 4 
RESULTS 
Figure 1 shows one of the demographic factors of race in the survey. The number of 
participants who identified as white were 20, while there were 23 participants who identified 
as black. The descriptive statistics (Table 1, Figure 1) for the question of whether each 
participant has a daughter describes the mean answer for the responses. As 1=yes, 2=no, 3=no 
answer, the most common answer was yes in that 39 participants have daughters. Figure 1 
shows the N Sample of 43 participants according to race.  
 
 
TABLE 1 – DESCRIPTIVE STATISTICS of PARTICIPANTS 
 
N sample of 43 mothers who do or do not have daughters.  
 
Descriptive Statistics       N Minimum Maximum Mean Std. Deviation 
None 43 1 43 22.00 12.557 
{1, yes; 2, no; 3 no answer} 43 1 2 1.09 .294 
{age 9-19} 43 1 3 1.21 .466 
Valid N (listwise) 43     
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FIGURE 1 – ETHNICITY DEMOGRAPHICS 
 
Table 2 describes those responded to the survey question of their knowledge of HPV 
and the HPV vaccine. The continuous variable for this question included: 1=very likely, 
2=somewhat likely, 3=somewhat unlikely, 4=very unlikely, and 5=don’t know. The results 
showed that the mean average answer was the same (2.37) for both questions which was 2 = 
somewhat likely of the participants having knowledge of both HPV and HPV vaccine. Figure 
2 shows that black mothers acknowledged having the greatest amount of knowledge of both 
HPV and the HPV vaccine. White mothers answered most of only being somewhat unlikely of 
having knowledge of the two variables (Figure 2).  
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TABLE 2 – HPV & HPV VACCINE KNOWLEDGE 
 
Those who have knowledge of HPV (1st row); those who have knowledge of HPV vaccine 
(2nd row). 
 
Descriptive Statistics      N   Minimum Maximum Mean Std. Deviation 
None 43 1 43 22.00 12.557 
{1, very likely; 2, somewhat 
likely; 3, somewhat unlikely; 
4, very unlikely; 5, unsure} 
43 1 5 2.37 1.113 
{1, very likely; 2, somewhat 
likely; 3, somewhat unlikely; 
4, very unlikely; 5, unsure} 
43 1 5 2.37 1.113 
Valid N (listwise) 43     
 
 
 
FIGURE 2 - HPV KNOWLEDGE  
This bar graph reflects the survey participant’s knowledge of HPV. The results are 
reflected by the race demographic of the participants. 
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Table 3 shows the standard mean answer is 1.58 where the participants answered yes 
to whether they will allow their daughter to receive the HPV vaccine and those who believe 
that the vaccine should be mandatory. The standard deviation for those who will allow their 
daughter to receive the vaccine is .626 while the standard deviation for those who believe the 
vaccine should be mandatory is .391. The difference in standard deviations shows that 
according to Figure 3, 12.5 white participants stated they would allow their daughter to 
receive the vaccine while 12.5 of black participants stated that they would not allow their 
daughter to receive the vaccine. Both the black and white participants were equal in stating 
that they do not believe the vaccine should be mandatory (Figure 3). 
 
Table 3 reflects the responses to the following questions: those who will allow 
daughter to receive vaccine (1st row); those who believe it should be mandatory (2nd row).  
 
TABLE 3 – PARTICIPANTS RESPONSE ON VACCINE ADMINISTRATION 
 
One-Sample Statistics       N   Mean Std. Deviation Std. Error Mean 
None 43 22.00 12.557 1.915 
{1, yes; 2, no; 3, no answer} 43 1.58 .626 .095 
{1, yes; 2, no; 3, no answer} 43 1.88 .391 .060 
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FIGURE 3 – PARTICIPANT RESPONSE TO DAUGHTER RECIEVING VACCINE 
This bar graph reflects the results to the question: Will you allow your daughter to 
 receive the HPV vaccine? The results were reflected based on the race 
 
 
 
FIGURE 4 – PARTICIPANT RESPONSE TO MANDATORY VACCINE 
This bar graph reflects those participants who believe the vaccine should be 
mandatory. The results are reflected by the race demographic. 
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Table 4 is the one-way ANOVA data which shows that 20 participants answered yes 
to allowing their daughter to receive the HPV vaccine (significance level .764). The degrees 
of freedom (df) showed that four participants had no answer in response to this question. The 
degrees of freedom was the same, however, 35 participants answered no to the question as to 
whether the HPV vaccine should be school mandated (significance level .461). 
 
Table 4 reflects answers of the question regarding the knowledge level of the HPV 
vaccine. The participants answered whether they would let their daughter receive the vaccine. 
The third row was of those who agree whether the vaccine should be school mandated.  
 
TABLE 4 – ANOVA DATA OF VACCINE QUESTION 
 
ANOVA 
Sum of 
Squares df Mean Square F Sig. 
None Between Groups 414.583 4 103.646 .634 .641 
Within Groups 6207.417 38 163.353   
Total 6622.000 42    
{1, yes; 2, no; 3, no 
answer} 
Between Groups .761 4 .190 .460 .764 
Within Groups 15.704 38 .413   
Total 16.465 42    
{1, yes; 2, no; 3, no 
answer} 
Between Groups .569 4 .142 .923 .461 
Within Groups 5.850 38 .154   
Total 6.419 42    
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FIGURE 5 - KNOWLEDGE OF VACCINE 
This bar graph reflects the participant response of their knowledge of the HPV Vaccine 
according to the race demographic. 
 
The results of the survey suggests that a mother’s knowledge of the HPV vaccine 
does have an effect on their decision to allow their daughter to receive the vaccine. The 
Pearson correlation -.044 as shown in Table 5, shows that those who answered “very likely” 
to having knowledge of the HPV vaccine were more likely to approve their daughter 
receiving the vaccine. The data below is based on a two-tailed significance level of .777. It is 
likely, that this survey can be used on a test-retest reliability basis and draw very similar 
results as the participants will most likely provide the same responses. The overall theme is 
that knowledge of a subject matter does play a role in how a person makes a decision.  
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Table 5 reflects those who answered if they would allow their daughter to receive the 
vaccine based on their knowledge of the HPV vaccine.  
 
TABLE 5 – CORRECLATIONS 
 
Correlations 
 
{1, yes; 2, no; 3, 
no answer} 
{1, vlikely; 2, 
slikely; 3, 
sunlikely; 4, 
vunlikely; 5, 
unsure} 
{1, yes; 2, no; 3, no answer} Pearson Correlation 1 -.044 
Sig. (2-tailed)  .777 
N 43 43 
{1, vlikely; 2, slikely; 3, 
sunlikely; 4, vunlikely; 5, 
unsure} 
Pearson Correlation -.044 1 
Sig. (2-tailed) .777  
N 43 43 
 
 Table 6 reflects the mean and standard deviations for questions 6, 7 & 14. Question 6 
asks the knowledge level of HPV. Question 7 asks the knowledge level of the HPV vaccine. 
Question 14 asks the interest level of attaining more information on both HPV and the HPV 
vaccine.  
 
TABLE 6 – ITEM STATISTIC FOR QUESTIONS 6, 7 & 14 
Item Statistics 
 Mean Std. Deviation N 
{1, vlikely; 2, slikely; 3, sunlikely; 4, 
vunlikely; 5, unsure} 8.60 5.595 5 
{1, vlikely; 2, slikely; 3, sunlikely; 4, 
vunlikely; 5, unsure} 8.80 6.535 5 
{1, vlikely; 2, slikely; 3, sunlikely; 4, 
vunlikely; 5, unsure} 8.60 7.232 5 
20 
 
 
 
 Table 7 reflects the Cronbach’s Alpha for questions 6, 7 and 14.  Question 6 and 7 
(list item 1 & 2) inquires the knowledge level of either HPV or the HPV vaccine. Question 
14 (list item 3) inquires the interest level to attain more information regarding HPV and the 
HPV vaccine.  
 
TABLE 7 – CROBACH’S ALPHA 
Item-Total Statistics 
 
Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected Item-
Total Correlation 
Cronbach's 
Alpha if Item 
Deleted 
{1, vlikely; 2, slikely; 3, 
sunlikely; 4, vunlikely; 5, 
unsure} 
17.40 150.300 .914 .736 
{1, vlikely; 2, slikely; 3, 
sunlikely; 4, vunlikely; 5, 
unsure} 
17.20 136.200 .840 .772 
{1, vlikely; 2, slikely; 3, 
sunlikely; 4, vunlikely; 5, 
unsure} 
17.40 146.800 .616 .992 
 
 Table 8 analyzes the variance in the answers for questions 6, 7 and 14.  These were 
the questions in the survey that had a direct impact on the participant response as to whether 
they will allow their daughter to receive the HPV vaccine and if it should be school 
mandated. 
 
TABLE 8 – SCALE STATISTICS FOR QUESTIONS 6, 7 & 14 
 
Scale Statistics 
Mean Variance Std. Deviation N of Items 
26.00 307.000 17.521 3 
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CHAPTER 5 
CONCLUSION 
The goal of this study was to determine if or when parents should have their daughters 
vaccinated for the HPV vaccine. According to the survey results, the age of the children was a 
major consideration as various states have been debating if it should be a mandatory school 
vaccination. The results showed that there was no demographic correlation between the 
demographics of the participants specifically the race and marital status. However, as shown 
in the previously recorded data in Chapter 3, the survey participants still believed that the 
vaccine should not be mandatory despite their knowledge level or their willingness to allow 
their daughter to receive the vaccine. The level of knowledge is what contributes to the 
concerns about the HPV vaccine.  
This study is an introduction to this current and rising issue and the sample size is 
relatively small. The Gardasil commercial, in which the girls state that they could be “one less” 
woman to develop cervical cancer, and the rumor that Gardasil was going to become a new 
vaccination for middle school girls were the inspirations on the decision to implement this 
small study. There are several limitations to this study. One limitation is that there weren’t 
many parents who elaborated on their answers. A second limitation was that demographics 
were not a factor in the validation of this study. A third limitation was that the study was only 
performed in two areas within the state of Michigan, therefore, the results do not speak enough 
to the general population of parental awareness of HPV and the HPV vaccine.  
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In summary of the survey, the number of mothers who answered yes to the question as 
to whether they would allow their daughter to receive the vaccine was 20. Only 7 mothers 
believed the HPV vaccine should be school mandated. Despite any level of knowledge of both 
HPV and the HPV vaccine, this study shows that it is preferred for the parent to have a choice 
in the decision of having the vaccine administered to their daughter. Many parents are not 
educated on the disease. Through this study, the participant answers were dominant in the 
“somewhat unlikely” category of answers when asked about their knowledge of HPV and the 
HPV vaccine. The level of knowledge does play a significant role in their views about the 
vaccine. Another parental concern is the long and short term effects of the disease. The 
education of a vaccination is important to parents because the disease could have side effects 
that they may want to prevent but have no knowledge of or the disease may be one that they 
will let their child decide as they get older. The vaccination may have severe side effects or 
other long term effects. Additionally, the moral concern of the use of the vaccination is to be 
considered as it can be viewed as a form of encouragement for children and teens to have pre-
marital sex.  
A concern regarding the acceptance of the vaccine is the mandate implemented by 
various states to make the vaccine mandatory for school age girls before they enter high school. 
Many parents may disagree with the vaccination because it only affects females. They may 
have other issues with the climbing number of vaccinations that are mandatory in schools. An 
additional concern is if parents will have the option to opt out of having their daughter take the 
vaccine.  
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This is clearly a topic that needs to be furthered discussed within the healthcare, 
government and educational systems to make the best suited decision on the vaccine mandate. 
It is also imperative to provide more educational tools to parents so they can make the right 
decision for their child. Bringing awareness on HPV and the vaccine options will definitely 
contribute to addressing the concerns of HPV and the potential health issues this disease can 
lead towards.  
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APPENDIX A 
 
To Whom It May Concern: 
 
 I am seeking parents of girls to participate in a mini educational study by this survey 
enclosed to help me complete my Masters of Education degree in Research and Evaluation. I 
attend Wayne State University and am an elementary teacher with Detroit Public Schools. My 
thesis is titled "Women Perception on Daughter Receive the Cervical Cancer Vaccine as a 
School Mandate?” the premise came from an article that I read in the American Teacher. The 
article stated that Michigan was one of the states debating if the cervical cancer vaccine, 
“Gardasil”, should become a mandated vaccine for school. Therefore, I became interested in 
what parents of students thought, so that brings me to asking you to participate in a mini 
educational survey to help me complete my thesis. If you have any questions feel free to contact 
me via e-mail: tiffany77@comcast.net subject: Gardasil. Feel free to pass it along to other 
parent with daughters. The more surveys completed the better.  
 
 
       Educationally Yours,   
       Tiffany F. Davis 
       Wayne State Student 
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APPENDIX B 
 
Survey on Parental Choice of HPV for Daughters 
 
1. Do you have a school age daughter?     Yes            No 
 
2. If yes on question 1, continue 
  Is she between the age of 9- 19?    Yes  No 
 
3. Which age group, if more than one (1) daughter circles all that applies or complete more                                
 than one (1) survey? 
    9yrs -11yrs     12yrs -15yrs    16yrs -19yrs 
 
4. Would you allow your daughter to 
receive the HPV vaccine?          Yes         No 
 
5. Do you think it should be a mandatory? 
School vaccine?       Yes   No 
 
     Very   Smwt  Smwt  Very  Don’t 
     Likely   likely unlikely unlikely know 
6. How much do you know? 
about HPV?               
 
7. How much do you know? 
about the HPV vaccine?              
 
 
How likely are you to get information about HPV or the HPV vaccine from these sources? 
     Very    Smwt        Smwt Very  Don’t 
     likely             likely      unlikely unlikely know 
 
     
8. A doctor, nurse, or health   
care provider                                
 
9. Internet                                      
 
10. Family members                              
 
11. Friends                        
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12. Magazines, books, television                     
 
13. School District                      
 
 
Very  Smwt  Smwt  Very  Don’t 
     Likely   likely unlikely unlikely know 
 
 
14. How interested are you  
 in getting information  
 about HPV or its vaccine?                   
 
 
15. What is your marital status? 
 
Married    Single    Live w/ Someone   Divorced     Widowed 
 
16. What is your race?   
   
White     Black      Hispanic   Asian  Other  
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APPENDIX C 
 
Survey Results on Parental Choice of HPV for Daughters 
 
1. Do you have a school age daughter?  Yes (39)           No (4) 
 
2. If yes on question 1, continue 
  Is she between the age of 9- 19? Yes (35)  No (8) 
 
3. Which age group, if more than one (1) daughter circle all that applies or complete more                                
 than one (1) survey? 
    9yrs -11yrs     12yrs -15yrs    16yrs -19yrs 
      (12)   (13)  (20) 
4. Would you allow your daughter to receive the HPV vaccine?   
 Yes (20)        No (19)   (4) Undecided 
  
5. Do you think it should be a mandatory school vaccine?     
                              Yes (7)   No (35) 
 
     Very   Smwt  Smwt  Very  Don’t 
     Likely   likely unlikely unlikely know 
6. How much do you know? 
about HPV?    
11   10   16         3  3  
 
7. How much do you know 
about the HPV vaccine?   
11   10   18         2  3 
 
 
How likely are you to get information about HPV or the HPV vaccine from these sources? 
     Very  Smwt        Smwt Very  Don’t 
     Likely   likely      unlikely unlikely know 
8. A doctor, nurse, or health  
care provider   
 20   15   6          1   1  
 
9. Internet       8   13   8           6    5  
 
10. Family members     3   8   8           15    8  
 
11. Friends    13  15   10          3    2 
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12. Magazines, books, television  3   18   8         12    2  
 
 
 
Very    Smwt Smwt  Very  Don’t 
     Likely     likely unlikely unlikely know 
 
13. School District    5     12   7          13    6  
 
14. How interested are you  
in getting information about  
HPV or its vaccine     19    11                  9           4     0 
 
 
15. What is your marital status? 
 
Married (29)    Single (9)   Live w/ Someone (1)   Divorced (4)    Widowed(0) 
 
16. What is your race?   
   
White  (20)   Black (23) Hispanic (0)     Asian (0)    Other (0)  
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ABSTRACT 
 
THE DEVELOPMENT OF A SURVEY TO ANALYZE IF THE HPV VACCINE IS 
APPROPRIATE FOR SCHOOL AGED GIRLS 
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The Human Papilloma Virus also known as HPV is a sexually transmitted disease. 
This particular STD consists of genital warts and can lead to cervical cancer in women. A 
HPV vaccine, Gardisil has been developed to help prevent the transmission of this particular 
STD. The topic of this paper is to discuss whether the HPV vaccine should be required to 
administer among female girls and adolescents. Despite the fact that the HPV vaccine is a 
preventative method for contracting HPV, many parents are not eager to accept this as a 
required vaccine to be administered to their daughter. One of the major reasons is due to lack 
of education about both HPV and the HPV vaccine. A study is performed to determine if 
parents are open to their child receiving the HPV vaccine and to test their knowledge of HPV 
and the HPV vaccine. The study concludes that parents do not have enough knowledge of 
HPV and the HPV vaccine to agree to the mandates that are being implemented throughout 
the United States to require female students to take the vaccine.  
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